SynthesisFrontiers in pediatrics2025
Prevalence of growth retardation among children and adolescents in China: a systematic review and meta-analysis.
Synthesis in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A novel method based on ultrasound radiomics for predicting attainment of near-adult height in adolescents.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The objective of this study was to determine the prevalence of growth delay in Chinese children and adolescents through a meta-analysis, providing scientific evidence for early intervention and prevention. Methods: Relevant studies on the prevalence of growth delay in Chinese children were retrieved from eight major databases: China National Knowledge Infrastructure (CNKI), Wanfang, Chongqing VIP, Chinese Biomedical Literature Database, PubMed, Embase, Cochrane Library, and Web of Science. Two researchers independently assessed the quality of the studies based on the inclusion criteria for cross-sectional studies outlined in the STROBE guidelines. Any discrepancies were resolved through cross-checking. Data extracted from studies were analyzed using Stata 15. Results: A total of 50 studies were included, with a sample size of 2,644,818 participants. The meta-analysis revealed that the overall prevalence of growth delay in Chinese children and adolescents was 5.7% (95% CI: 5.3%-6.2%). Subgroup analysis by age demonstrated the following prevalence rates: 7.4% (95% CI: 6.6%-8.3%) for ages 0-2 years, 6.8% (95% CI: 6.1%-7.4%) for ages 3-6 years, 3.9% (95% CI: 3.6%-4.2%) for ages 6-12 years, and 3.0% (95% CI: 2.3%-3.6%) for ages 13-18 years. Statistically significant differences were observed between age groups ( Conclusion: The prevalence of growth delay in Chinese children and adolescents is gradually decreasing, with variations across age groups and residential environments. Efforts to alleviate this issue should include enhanced public health awareness, promotion of healthy lifestyles, improved family nutrition education and training, and strengthening of the healthcare system. Systematic Review Registration: CRD42024579022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.